Martin Fehr
Impact in
- Finance top 10%
- Financial Markets and Investment Strategies
- Accounting top 10%
- Corporate Finance and Governance
Papers in
- Genetics 4
- Chronic Lymphocytic Leukemia Research 4
-
- Multiple Myeloma Research and Treatments 2
- Co-authors
- Manuel AmmannWalter H. ReinhartRichard CathomasMatthew WheaterT. GeldartDirk KlingbielRoger von MoosSimon J. Crabb
- Journals
- Annals of Oncology (3 papers)Swiss Medical Weekly (2 papers)Journal of Thoracic Oncology (1 paper)Oncology Reports (1 paper)ESMO Open (1 paper)
- Partner nations
- SwitzerlandUnited KingdomGermany
In The Last Decade
Martin Fehr
21 papers receiving 209 citations
Peers
Comparison fields: 5 of 63
- Finance 39
- Accounting 43
- Nephrology 16
- Internal Medicine 7
- Strategy and Management 26
Countries citing papers authored by Martin Fehr
This map shows the geographic impact of Martin Fehr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Fehr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Fehr more than expected).
Fields of papers citing papers by Martin Fehr
This network shows the impact of papers produced by Martin Fehr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Fehr. The network helps show where Martin Fehr may publish in the future.
Co-authors
The 25 scholars most cited alongside Martin Fehr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2020 | 4 | |
| 3 | 2019 | 12 | |
| 4 | 2018 | 5 | |
| 5 | 2017 | 3 | |
| 6 | 2016 | 0 | |
| 7 | 2015 | 9 | |
| 8 | 2015 | 26 | |
| 9 | 2014 | 8 | |
| 10 | 2014 | 24 | |
| 11 | 2013 | 8 | |
| 12 | 2011 | 8 | |
| 13 | 2010 | 5 | |
| 14 | 2010 | 2 | |
| 15 | 2009 | 3 | |
| 16 | 2008 | 10 | |
| 17 | 2008 | 22 | |
| 18 | 2007 | 5 | |
| 19 | 2004 | 9 | |
| 20 | Skin diseases in pet rabbits and rodents. | 1990 | 1 |
About Martin Fehr
Martin Fehr is a scholar working on Genetics, Hematology, Internal Medicine, Neurology and Oncology, having authored 25 papers that have together received 215 indexed citations. Recurring topics across this work include Testicular diseases and treatments (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Neuroblastoma Research and Treatments (3 papers), Corporate Finance and Governance (2 papers), Multiple Myeloma Research and Treatments (2 papers), Cancer Treatment and Pharmacology (2 papers) and Esophageal Cancer Research and Treatment (2 papers). The work is most often cited by research in Finance (39 citations), Accounting (43 citations), Nephrology (16 citations), Internal Medicine (7 citations) and Strategy and Management (26 citations). Martin Fehr has collaborated with scholars based in Switzerland, United Kingdom and Germany. Frequent co-authors include Manuel Ammann, Walter H. Reinhart, Richard Cathomas, Matthew Wheater, T. Geldart, Dirk Klingbiel, Roger von Moos, Simon J. Crabb, Hannah Markham and O. R. Koechli. Their work appears in journals such as Annals of Oncology, Swiss Medical Weekly, Journal of Thoracic Oncology, Oncology Reports and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.